Clinical Trials · NCT00225420
Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Enrollment
- 23
- Start date
- Aug 2005
- Locations
- 2 sites, United States
- Primary endpoint
- Number of Patients Experiencing Dose-Limiting Toxicities